Basics Axogen, Inc. Common Stock AxoGen Inc is a medical technology company dedicated to peripheral nerve repair. It provide products and education to improve surgical treatment algorithms for peripheral nerve injuries. IPO Date: January 1, 1987 Sector: Healthcare Industry: Health Care Equipment and Supplies Market Cap: $780.83M Activated in VL: True Average Daily Range Avg Daily Range: $0.31 | 2.45% Avg Daily Range (30 D): $0.31 | 1.82% Avg Daily Range (90 D): $0.30 | 2.11% Institutional Daily Volume Avg Daily Volume: .26M Avg Daily Volume (30 D): .74M Avg Daily Volume (90 D): 1M Trade Size Avg Trade Size (Sh.): 92 Avg Trade Size (Sh.) (30 D): 91 Avg Trade Size (Sh.) (90 D): 84 Institutional Trades Total Inst.Trades: 1,206 Avg Inst. Trade: $1.3M Avg Inst. Trade (30 D): $1.41M Avg Inst. Trade (90 D): $1.61M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.32M Avg Closing Trade (30 D): $1.44M Avg Closing Trade (90 D): $1.54M Avg Closing Volume: 80.55K     News Oct 1, 2025 @ 2:50 PM AXGN Investors Have Opportunity to Join Axogen, In... Source: Business Wire Jul 30, 2025 @ 5:00 PM Global Amniotic Membrane Market Poised for Extraor... Source: Delveinsight Feb 11, 2025 @ 9:58 PM Axogen, Inc. to report 2024 fourth quarter and ful... Source: N/A Oct 7, 2024 @ 7:45 PM Bruker Stock Gains From Its Latest Acquisition of ... Source: Zacks Oct 3, 2024 @ 4:50 PM Here's Why You Should Retain BRKR Stock in Your Po... Source: Zacks Financials   TTM Q1 2025 Q4 2024 Basic EPS $.01 $-.08 $.01 Diluted EPS $.01 $-.08 $.01 Revenue $ 56.66M $ 48.56M $ 49.41M Gross Profit $ 42.02M $ 34.93M $ 37.58M Net Income / Loss $ .58M $ -3.83M $ .45M Operating Income / Loss $ 1.67M $ -1.66M $ 2.02M Cost of Revenue $ 14.64M $ 13.63M $ 11.83M Net Cash Flow $ 1.94M $ -9.46M $ 8.89M PE Ratio 1,769.00